{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "KLF4",
                "DNA Alteration": "c.1225A>C",
                "GeneMutation": "p.K409Q Frameshift-LOF",
                "VariantAlleleFraction": "5.63%"
            },
            {
                "Gene": "U2AF1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.R156X Nonsense-GOF",
                "VariantAlleleFraction": "7.36%"
            },
            {
                "Gene": "DNMT3A",
                "DNA Alteration": "c.2711C>T",
                "GeneMutation": "p.P904L Nonsense-LOF",
                "VariantAlleleFraction": "7.03%"
            },
            {
                "Gene": "BRAF",
                "DNA Alteration": "c.1798_1799delinsAG",
                "GeneMutation": "p.V600A Spliceregionvariant-GOF",
                "VariantAlleleFraction": "5.63%"
            },
            {
                "Gene": "RB1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.F650S Nonsense-LOF",
                "VariantAlleleFraction": "4.38%"
            },
            {
                "Gene": "ZEB2",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.H1038R Frameshift-LOF",
                "VariantAlleleFraction": "9.93%"
            },
            {
                "Gene": "ZEB2",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.H1038R Spliceregionvariant-GOF",
                "VariantAlleleFraction": "4.81%"
            },
            {
                "Gene": "MTOR",
                "DNA Alteration": "c.5662T>C",
                "GeneMutation": "p.G1954R Nonsense-LOF",
                "VariantAlleleFraction": "4.41%"
            },
            {
                "Gene": "BRAF",
                "DNA Alteration": "c.1405G>C",
                "GeneMutation": "p.L597V Nonsense-LOF",
                "VariantAlleleFraction": "3.01%"
            },
            {
                "Gene": "U2AF1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.S34X Spliceregionvariant-LOF",
                "VariantAlleleFraction": "1.45%"
            },
            {
                "Gene": "FGFR3",
                "DNA Alteration": "c.1138G>A",
                "GeneMutation": "p.G380R Frameshift-GOF",
                "VariantAlleleFraction": "1.09%"
            },
            {
                "Gene": "KIT",
                "DNA Alteration": "c.2492T>C",
                "GeneMutation": "p.D820Y Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "2.89%"
            }
        ],
        "Germline": []
    }
}